Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
248.68
-3.32 (-1.32%)
At close: Nov 20, 2026
SHA:688506 Market Cap
SHA:688506 has a market cap or net worth of 102.29 billion as of November 20, 2026. It is the 1,436th most valuable company in the world and the 115th biggest in China. Its market cap has decreased by 32.92% in one year.
Market Cap
102.29B
Enterprise Value
102.44B
Revenue
2.55B
Global Rank
Country Rank
#115 China
PE Ratio
n/a
ChartMarket Cap Chart
Since January 6, 2023, SHA:688506's market cap has increased from 12.85B to 102.29B, an increase of 695.87%. That is a compound annual growth rate of 70.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 102.29B | -23.32% |
| Dec 31, 2025 | 133.40B | 73.51% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
| Jan 6, 2023 | 12.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 313.47B |
| Yunnan Baiyao Group Co.,Ltd | 100.44B |
| Zhejiang NHU Company | 79.88B |
| Shanghai Fosun Pharmaceutical (Group) | 50.82B |
| Huadong Medicine | 44.90B |
| China Resources Sanjiu Medical & Pharmaceutical | 43.95B |
| Dong-E-E-Jiao | 33.63B |
| Humanwell Healthcare (Group) | 33.17B |